Alopecia Totalis Clinical Trials Alopecia Totalis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
Conditions:   Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis Intervention:   Drug: ATI-50002 Sponsor:   Aclaris Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials